Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
Ordina per
Keyphrases
Randomized Placebo-controlled Trial
100%
Phase I Trial
100%
Elderly Volunteers
100%
SIRT1 Activator
100%
SRT2104
100%
Clinical Trials
28%
Pharmacokinetics
28%
Oral Glucose Tolerance Test
28%
Sirtuin 1 (SIRT1)
28%
Phosphorus-31 Magnetic Resonance Spectroscopy
28%
Whole-body
14%
Lipid Metabolism
14%
Further Development
14%
Triglycerides
14%
Metabolic Pathway
14%
Oxidative Stress
14%
Placebo
14%
Biological Effects
14%
Oral Dose
14%
Glucose Metabolism
14%
Type 2 Diabetes Mellitus (T2DM)
14%
Study Support
14%
Energy Homeostasis
14%
Therapeutic Target
14%
Magnetic Resonance Imaging
14%
Pharmacodynamics
14%
Adenosine Diphosphate
14%
Trial Registration
14%
Elderly People
14%
Once-daily
14%
Dyslipidemia
14%
Cholesterol LDL
14%
Serum Cholesterol
14%
Age-related Illnesses
14%
Tmax
14%
Serum Lipids
14%
Visceral Fat
14%
Test Response
14%
Mitochondrial Oxidative Phosphorylation
14%
Dose Selection
14%
LDL Levels
14%
Multiple-ages
14%
Stress Metabolism
14%
Capacity Test
14%
Maximal Aerobic Speed
14%
Phosphocreatine Recovery
14%
Subcutaneous Fat
14%
NAD+-dependent Deacetylase
14%
Elimination Half-life
14%
Mitochondrial Oxidative Capacity
14%
SIRT1 Activation
14%
Small Molecule Activation
14%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Placebo
100%
Phase I Trials
100%
Phosphorus 31
100%
Pharmacokinetics
100%
Pharmacodynamics
50%
Elimination
50%
Adenosine Diphosphate
50%
Triacylglycerol
50%
Low Density Lipoprotein Cholesterol
50%
Dyslipidemia
50%
Creatine Phosphate
50%
Diseases
50%
Maturity Onset Diabetes of the Young
50%